NL-OMON34587已完成不适用
ANCA-associated Vasculitis and the Metabolic Syndrom - AAV and the MetSyn
Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Age: > 18 years
- •- Diagnosis: ANCA-associated vasculitis according to the classification criteria of Watts et al.
- •- Known with the disease for more than 1 year.;Healthy controles:
- •- Partner of included patient.
排除标准
- •- Patients do not fulfil the classification criteria of Watts et al.
- •- Under aged and legally incapable.
- •- Immunosuppressive medication: > 15 mg prednison;Healthy controles:
- •- Under aged and legally incapable
研究者
相似试验
Unknown
不适用
Cardiovascular disease in ANCA-associated vasculitisANCA-associated vasculitisNL-OMON24348orthwest Academy210
进行中（未招募）
不适用
SE OF ABATACEPT IN ANCA-ASSOCIATED VASCULITIS - ABAVASEUCTR2008-004138-26-ITAZIENDA OSPEDALIERA DI PARMA112
招募中
不适用
Refractory ANCA Associated Vasculitis and Lupus Nephritis Treated With BCMA-targeting CAR-T CellsANCA Associated VasculitisLupus NephritisNCT06277427Lingli Dong24
招募中
1 期
Imlifidase for the treatment of autoimmune-mediated small blood vessel inflammatioEUCTR2021-004706-22-DECharité - Universitätsmedizin Berlin10
尚未招募
不适用
Study the assosciation of severity of acanthosis nigricans with the metabolic syndromeCTRI/2022/05/042703Pandit BD Sharma PGIMS Rohtak